Valisure

September's Member Meeting is set to be enlightening with David Y. Light, Co-Founder & President of Valisure, and Victor Suarez, Founder & Principal Growth Partner of Blu Zone Bioscience & Supply Chain Solutions, LLC. They will delve into the root causes of #drugsupply quality issues, presenting practical solutions. Registration is exclusive to Members and invited Guests. #pharmaceuticals #healthtalk #supplychain

We are thrilled to share our recent feature on Bloomberg Originals, "The Tiny Lab Finding Danger in Your Medicine Cabinet," narrated by Bloomberg's national healthcare reporter, Anna Edney. This nearly 9-minute video delves into #Valisure's mission to protect consumers by identifying potentially dangerous items in their medicine cabinets. Amid numerous drug and product recalls from major brands, Valisure's name has become synonymous with vigilance and safety. We are grateful to Bloomberg News for highlighting our impactful work and commitment to consumer safety. Watch the full video to learn more about our journey and the positive changes we're striving to make. #Valisure #ConsumerSafety #Healthcare #BloombergOriginals

We're #hiring a new Research Associate in New Haven, Connecticut. Apply today or share this post with your network.

Over the past few years, our dedicated team of scientists at Valisure has successfully identified potentially harmful chemicals in common products, ranging from medications and sunscreens to hand sanitizers and dry shampoos. These findings have sparked widespread media coverage, led to numerous product recalls, and catalyzed significant changes in industry practices. As highlighted in a recent 15-minute feature by TIME's Jamie Ducharme, our work not only leads to safer consumer choices but also drives regulatory discussions and actions, emphasizing the critical role of independent testing within our current regulatory framework. At #Valisure, we are committed to enhancing public health through transparency and information. We strive to ensure that consumers are well-informed about the contents of the products they use daily. Join us on our mission to transform product safety and uphold the highest standards of consumer protection.

From our April cover: Benzoyl peroxide has been a hot topic in both dermatology and consumer headlines after news broke about high levels of benzene found in BPO-containing acne products such as cleansers, lotions, and gels. Take an in-depth look at the basis of Valisure's benzene testing methods and practical recommendations for clinicians from Christopher Bunick, MD, PhD. https://lnkd.in/gKuEz4NU

NEW: Carcinogenic benzene is a degradation product of benzoyl peroxide, widely used in topical acne treatments. Kucera et al. tested 7 such products and found that all formed benzene—including 2 that emitted the gas from unopened containers ➡️ https://ow.ly/Q8Z850QTtKT Valisure

The popular acne treatment molecule benzoyl peroxide can decompose into benzene in common product formulations, according to findings by the contract analytical lab Valisure. The situation is more complex than in previous recent benzene findings. Read more in C&EN https://lnkd.in/en4F_utn

At #AAD2024, Christopher Bunick, MD, PhD, presented updates on #benzene in #benzoylperoxide. The findings of benzene in BPO products were validated by 3 different labs using 4 different technology platforms, including GC-MS, GC-HRMS, HPLC, and SIFT-MS. Bunick also reiterated Valisure's stability testing, which is not meant to replicate consumer use or “real-world” use. Stability testing is intended to evaluate the full, 3-year product “life cycle.” 3-year stability at room temperature is equal to 169 days at 50°C or 122°F which is based on industry standards. It is a regulatory requirement to perform stability testing on products and should be conducted on products under normal storage conditions, or, preferably, under exaggerated conditions, according to the FDA. https://lnkd.in/gvmYmuUg

🚨NEW TONIGHT: David Light, co-founder and president of Valisure LLC, the independent laboratory behind yesterday's #benzene findings in benzoyl peroxide- containing acne products from major corporations, unpacks the data, emphasizes the importance of stability testing, and addresses online discourse. Dermatology Times Winter Editor in Chief Christopher Bunick, MD, PhD, contributes to the conversation and advises dermatologists on interpreting the news. Read more at the link below, and view our detailed video interview with Light. https://lnkd.in/gaGw4n8W

🔬 Understanding the Dynamics of Stability Testing 🔍 Valisure recently announced its detection of benzene in benzoyl peroxide products. We understand this is a complex topic and want to share further information of the importance of stability testing. The purpose of stability studies is not to copy the conditions of an average consumer, rather, the purpose is to ensure the product is safe to use for the entire products lifecycle, from manufacturing through distribution to its expiration date, often a total of 3 years for pharmaceutical products. Products must be stable during this entire time and through all the possible “bumps” along the road. The benzene found in these benzoyl peroxide products is a very different situation from the benzene contamination in sunscreens and other products where the benzene was a raw material contaminant and the amount of benzene "on the shelf" would not change. Even if a product is clean when purchased, it can form high levels of benzene over time, even sitting in a medicine cabinet. This is where the crucial importance of stability studies come in, which are regulatory requirements. Read more about the importance of this testing method via the link here: